Upsher-Smith honored with HDA Diana AwardUpsher-Smith was named best overall branded pharmaceutical product manufacturer in its sales category for the fourth consecutive year. Strides Pharma announces completion of Bharat Dhirajlal Shah’s tenure as independent directorShah has been associated with Strides since July 2014. Alembic secures FDA approval for generic Pradaxa Dabigatran Etexilate Capsules are indicated for reduction of risk of stroke and systemic embolism in certain instances. Cranbury Pharmaceuticals receives FDA nod for generic Emflaza Deflazacort oral suspension is indicated to treat patients five years of age and older for Duchenne muscular dystrophy. Cipla receives FDA OK for generic Somatuline Depot Cipla’s lanreotide injection is indicated for the treatment of patients with acromegaly and gastroenteropancreatic neuroendocrine tumors. Lupin taps Abdelaziz Toumi as CEO of API CDMO subsidiary Toumi brings more than two decades of experience in the biotech, pharma and CDMO sectors, spanning Europe, North America and Asia. Alembic obtains FDA nod for generic Firazyr Generic Firazyr is used for the treatment of acute attacks of hereditary angioedema in adults 18 years of age and older. Glenmark receives FDA OK for generic Nexium Esomeprazole magnesium delayed-release capsules, 20 mg (OTC), will be distributed in the United States by Glenmark Therapeutics. Amneal, FTC reportedly win order removing Teva inhaler patents from FDA list The decision comes after the FTC's warnings to drugmakers over the misuse of Orange Book patent listings to wrongly extend patent monopolies on brand-name drugs, per a Reuters report. Alvotech, STADA add to strategic alliance through denosumab partnership AVT03 is a clinical-stage biosimilar candidate referencing the Prolia/Xgeva medicines for osteoporosis and cancer-related bone loss, respectively. First Previous 36 37 38 39 40 Next Last
